This inventor holds 1 USPTO granted patent. Top assignee: New England Nuclear Corporation. Active years: 1981.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981
Title: Maria P Liteplo: Innovator in Technetium-99m Reduction
Introduction
Maria P Liteplo is a notable inventor based in Bedford, MA (US). She has made significant contributions to the field of radiochemistry, particularly in the development of reducing agents for technetium-99m. Her work has implications for medical imaging and diagnostics, showcasing her innovative spirit and dedication to advancing scientific knowledge.
Latest Patents
Maria P Liteplo holds a patent for a "Reductant composition for technetium-99m and method for making." This patent describes a reductant composition that effectively reduces technetium from the +7 oxidation state, allowing for the production of technetium-labelled ligands. The process involves mixing ligands with pertechnetate in the presence of the reductant, followed by the separation of the reductant from the resulting labelled ligand. This innovation is crucial for creating technetium labelled ligands that are substantially free from the reducing agent used in their preparation.
Career Highlights
Maria has been associated with New England Nuclear Corporation, where she has applied her expertise in radiochemistry. Her work has not only contributed to the company's research but has also advanced the field of medical imaging. With her patent, she has established herself as a key figure in the development of new technologies that enhance diagnostic capabilities.
Collaborations
Maria P Liteplo has collaborated with Leopoldo Lazaro Camin, working together to further their research and innovations in the field of radiochemistry. Their partnership exemplifies the importance of teamwork in scientific advancements.
Conclusion
Maria P Liteplo's contributions to the field of technetium-99m reduction highlight her innovative approach and commitment to improving medical diagnostics. Her patent and work at New England Nuclear Corporation reflect her significant impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile